טוען...
Glioblastoma Treatment: Bypassing the Toxicity of Platinum Compounds by Using Liposomal Formulation and Increasing Treatment Efficiency With Concomitant Radiotherapy
PURPOSE: Treatments of glioblastoma (GBM) with cisplatin or oxaliplatin only marginally improve the overall survival of patients and cause important side effects. To prevent adverse effects, improve delivery and optimize the tumor response to treatment in combination with radiotherapy, a potential a...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3828172/ https://ncbi.nlm.nih.gov/pubmed/22284691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2011.10.054 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|